The Future of Open Access, on Demand R&D: Spotlight Talk with Strateos

The Future of Open Access, on Demand R&D: Spotlight Talk with Strateos

Thursday, October 1, 2020 4:00 PM to 4:05 PM · 5 min. (Africa/Abidjan)
October 1

Information

If you think it's a pipe dream to design, produce, and analyze your synthetic biology product all from your laptop, it's time to think again. Join Strateos CEO Mark Fischer-Colbrie to learn how his company is taking all the processes, instruments, and robotics you’d find in a big pharmaceutical R&D facility and making them accessible to anybody with a laptop and a good idea.


StrateosStrateos, formerly Transcriptic and 3Scan, is the leading provider of remote access and on-demand discovery life science. The company automates medicinal chemistry, biological analyses and synthetic biology into closed-loop robotic labs that accelerate discovery programs for researchers around the world.  Through a combination of best-in-class robotics and control systems, and advanced software for analytics, the Strateos Robotic Cloud Lab platform enables unparalleled scale, efficiency, and accuracy for the drug discovery process. Discover more at strateos.com.

Registered attendees

Avencia Sanchez-Mejia
Avencia Sanchez-Mejia
Senior Biomedical ScientistUniversitat Pompeu Fabra
BB
Behnaz Behrouzian
Sr. Director, Analytical BiochemistryCodexis
Bhaskar Bhadra
Bhaskar Bhadra
Asst. Vice-PresidentReliance Industries Limited

Log in